<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2007</study_start_year><condition>Metastatic Colorectal Cancer</condition><condition>Colorectal Neoplasms</condition><disease>Metastatic Colorectal Cancer</disease><disease>Colorectal Neoplasms</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2038811</full_dataset_link><location>Singapore</location><location>Hong Kong</location><location>Cyprus</location><location>Czechia</location><location>Thailand</location><location>Portugal</location><location>Russia</location><location>South Korea</location><location>Sweden</location><location>Austria</location><location>Ireland</location><location>Poland</location><location>Brazil</location><location>Slovakia</location><location>Serbia</location><location>Bulgaria</location><location>Chile</location><location>Bosnia and Herzegovina</location><location>Colombia</location><location>Argentina</location><location>Romania</location><location>Hungary</location><location>Ukraine</location><location>United Kingdom</location><location>India</location><location>Spain</location><location>Canada</location><location>Belgium</location><location>Norway</location><location>Taiwan</location><location>Mexico</location><location>South Africa</location><location>Australia</location><location>Germany</location><study_start_month>6</study_start_month><keyword>Irinotecan</keyword><keyword>Sunitinib</keyword><keyword>Levoleucovorin</keyword><keyword>Leucovorin</keyword><keyword>Fluorouracil</keyword><repository>ECRIN MDR</repository><study_status>Completed</study_status></additional><is_claimable>false</is_claimable><name>Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal Cancer</name><description>The purpose of the study is to evaluate the safety and efficacy of FOLFIRI (Irinotecan, Leucovorin and 5 Fluorouracil) chemotherapy when combined with sunitinib or FOLFIRI chemotherapy without adding sunitinib as the first line treatment of patients with metastatic colorectal cancer.</description><dates><creation>2007-06-15</creation></dates><accession>2038811</accession><cross_references><ClinicalTrials___gov>NCT00457691</ClinicalTrials___gov><Clinical Trials Registry - India>CTRI-2011-091-000025</Clinical Trials Registry - India></cross_references></HashMap>